Search Results
Instituto de Investigación en Biomedicina de Buenos Aires – CONICET, Departamento de Fisiología, Partner Institute of the Max Planck Society, Buenos Aires, Argentina
Search for other papers by Fernando Aprile-Garcia in
Google Scholar
PubMed
Instituto de Investigación en Biomedicina de Buenos Aires – CONICET, Departamento de Fisiología, Partner Institute of the Max Planck Society, Buenos Aires, Argentina
Search for other papers by María Antunica-Noguerol in
Google Scholar
PubMed
Search for other papers by Maia Ludmila Budziñski in
Google Scholar
PubMed
Search for other papers by Ana C Liberman in
Google Scholar
PubMed
Instituto de Investigación en Biomedicina de Buenos Aires – CONICET, Departamento de Fisiología, Partner Institute of the Max Planck Society, Buenos Aires, Argentina
Search for other papers by Eduardo Arzt in
Google Scholar
PubMed
action during inflammation (23, 24) . GCs exert their biological effects binding to the glucocorticoid receptor (GR), which is a ligand-activated TF that regulates the expression of target genes, either positively or negatively (18, 25) . In an
Search for other papers by Kathrin Zopf in
Google Scholar
PubMed
Search for other papers by Kathrin R Frey in
Google Scholar
PubMed
Search for other papers by Tina Kienitz in
Google Scholar
PubMed
Search for other papers by Manfred Ventz in
Google Scholar
PubMed
Search for other papers by Britta Bauer in
Google Scholar
PubMed
Search for other papers by Marcus Quinkler in
Google Scholar
PubMed
Introduction Polymorphisms of the glucocorticoid receptor (GR) may influence the sensitivity to glucocorticoids by altering the GR expression (e.g. reducing transcription) and influencing transactivation and transrepression of target genes
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by Anne-Sophie C A M Koning in
Google Scholar
PubMed
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by Philippe C Habets in
Google Scholar
PubMed
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by Marit Bogaards in
Google Scholar
PubMed
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by Jan Kroon in
Google Scholar
PubMed
Department of Pediatric Neuro-Oncology, Prinses Máxima Centrum, Utrecht, The Netherlands
Search for other papers by Hanneke M van Santen in
Google Scholar
PubMed
Search for other papers by Judith M de Bont in
Google Scholar
PubMed
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by Onno C Meijer in
Google Scholar
PubMed
study the biological mechanisms of action that underlie them, and this might help to decrease these adverse effects during glucocorticoid therapy. Synthetic glucocorticoids target the glucocorticoid receptor (GR), one of the two receptor types for the
Department of Rheumatology and Clinical Immunology, Charité-University Medicine, Berlin, Germany
Search for other papers by Janko Sattler in
Google Scholar
PubMed
Bone Research Program, ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia
Concord Clinical School, The University of Sydney, Sydney, Australia
Search for other papers by Jinwen Tu in
Google Scholar
PubMed
Search for other papers by Shihani Stoner in
Google Scholar
PubMed
Key Laboratory for Space Bioscience and Biotechnology, Institute of Special Environmental Biophysics, School of Life Sciences, Northwestern Polytechnical University, Shaanxi, China
Search for other papers by Jingbao Li in
Google Scholar
PubMed
Search for other papers by Frank Buttgereit in
Google Scholar
PubMed
Concord Clinical School, The University of Sydney, Sydney, Australia
Department of Endocrinology & Metabolism, Concord Hospital, Sydney, Australia
Search for other papers by Markus J Seibel in
Google Scholar
PubMed
Concord Clinical School, The University of Sydney, Sydney, Australia
Search for other papers by Hong Zhou in
Google Scholar
PubMed
Concord Clinical School, The University of Sydney, Sydney, Australia
Department of Endocrinology & Metabolism, Concord Hospital, Sydney, Australia
Search for other papers by Mark S Cooper in
Google Scholar
PubMed
then blocked with 5% goat serum for 30 min and incubated overnight with the primary antibody for 11β-HSD1 (1:100, Cayman Chemicals) and glucocorticoid receptor (GR) (1:400, sc-1004, Santa Cruz Biotechnology). A biotinylated secondary antibody was
Search for other papers by Yan-yu Zhang in
Google Scholar
PubMed
Search for other papers by Xian Zhang in
Google Scholar
PubMed
Search for other papers by Shao-yang Bu in
Google Scholar
PubMed
Search for other papers by Wei-wei Zhang in
Google Scholar
PubMed
Search for other papers by Tian-xiu Li in
Google Scholar
PubMed
Search for other papers by De-cai Zheng in
Google Scholar
PubMed
Search for other papers by Ze-xiang Huang in
Google Scholar
PubMed
Search for other papers by Qian Wang in
Google Scholar
PubMed
, and kiss2 is considered to be the key regulatory gene in reproductive function ( 21 ). In goldfish, the GRE domain is found in the promoter region of kiss gene, suggesting that kisspeptin may be regulated by glucocorticoid receptor (GR) ( 43 ). It
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Search for other papers by Sirazum Choudhury in
Google Scholar
PubMed
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Search for other papers by Tricia Tan in
Google Scholar
PubMed
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Search for other papers by Katharine Lazarus in
Google Scholar
PubMed
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Search for other papers by Karim Meeran in
Google Scholar
PubMed
easily obtainable cells that are representative of peripheral tissue. They showed a 2.8-fold greater acetylation of the glucocorticoid receptor (GR) in the morning than in the evening. With acetylation of the GR attenuating the transcriptional response of
Search for other papers by Jian Gong in
Google Scholar
PubMed
Search for other papers by Yinjuan Lv in
Google Scholar
PubMed
Search for other papers by Yuhao Meng in
Google Scholar
PubMed
Search for other papers by Weiheng Zhang in
Google Scholar
PubMed
Search for other papers by Xiaocui Jiang in
Google Scholar
PubMed
Search for other papers by Min Xiao in
Google Scholar
PubMed
, hematoxylin-eosin (Wuhan Xavier Biotechnology Co., Ltd., Article No. GB11002, GB23303, G2020, G1121, G1076). antibody to KISS1-R protein, antibody to glucocorticoid receptor (GR) protein, antibody to Bax protein, antibody to BCL-2 protein, antibody to Caspase
Search for other papers by Marcus Quinkler in
Google Scholar
PubMed
Search for other papers by Bertil Ekman in
Google Scholar
PubMed
Search for other papers by Claudio Marelli in
Google Scholar
PubMed
Search for other papers by Sharif Uddin in
Google Scholar
PubMed
Search for other papers by Pierre Zelissen in
Google Scholar
PubMed
Search for other papers by Robert D Murray in
Google Scholar
PubMed
Search for other papers by on behalf of the EU-AIR Investigators in
Google Scholar
PubMed
development of corticosteroid side effects between patients ( 7 ). Interestingly, when the endogenous glucocorticoid, cortisol (hydrocortisone), is compared with prednisolone at the isolated human glucocorticoid receptor (GR), the transactivation activity of
Search for other papers by Masatada Watanabe in
Google Scholar
PubMed
Search for other papers by Shuji Ohno in
Google Scholar
PubMed
Search for other papers by Hiroshi Wachi in
Google Scholar
PubMed
-AR signaling pathway is an increase in cyclic AMP (cAMP) concentration ([cAMP]i). An increase in [cAMP]i and activation of protein kinase A (PKA) might interfere with the action of ligand-occupied glucocorticoid receptor (GR). To better understand the mechanism
Search for other papers by David J F Smith in
Google Scholar
PubMed
Search for other papers by Hemanth Prabhudev in
Google Scholar
PubMed
Department of Clinical Biochemistry, Imperial College Healthcare NHS Trust, London, UK
Department of Investigative Medicine, Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK
Search for other papers by Sirazum Choudhury in
Google Scholar
PubMed
Department of Investigative Medicine, Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK
Search for other papers by Karim Meeran in
Google Scholar
PubMed
mineralocorticoid production in primary adrenal failure. The mainstay of treatment is glucocorticoid replacement, with either hydrocortisone or prednisolone ( 2 ). Both work by binding to the glucocorticoid receptor (GR) for which prednisolone has the greater